Press release
Ascites Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight
Key Takeaways from the Ascites Market Report
* In 2020, the total cases of Ascites due to cirrhosis in the 7MM were ~240,700. Malignant Ascites cases are calculated from ovarian cancer, stomach cancer, breast cancer, and colorectal cancer. In 2020, the number of cases of Ascites from these cancers was ~8,500; ~3,500; ~12,650; and ~10,300, respectively, in the US.
* The increase in Ascites Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
* As per DelveInsight analysis, the Ascites Market is anticipated to witness growth at a considerable CAGR.
* The leading Ascites Companies working in the market include Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.
* Promising Ascites Therapies in the various stages of development include catumaxomab, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP Registered ), M701, Paracentesis, Recombinant Human Serum Albumin, and others.
* February 2024:- Wuhan YZY Biopharma Co., Ltd. announced a study of Phase 2 clinical trials for M701 and paracentesis. The phase II study is a controlled, open-label trial designed to assess the effectiveness and safety of M701 intra-peritoneal infusion for controlling malignant ascites in patients with gastrointestinal and ovarian cancer who are also receiving systemic therapy.
Discover which therapies are expected to grab the Ascites Market Share @ Ascites Market Outlook [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Ascites Overview
Ascites is a medical condition characterized by the accumulation of fluid in the abdomen. This fluid buildup occurs in the space between the lining of the abdomen and the organs. It's commonly associated with liver disease, particularly cirrhosis, but can also be caused by other conditions such as heart failure, cancer, or infection. Ascites can lead to abdominal swelling, discomfort, and difficulty breathing. Treatment typically involves addressing the underlying cause, reducing fluid intake, medications to remove excess fluid, and sometimes procedures to drain the fluid.
Ascites Epidemiology Insights
The epidemiology section of Ascites offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Ascites Epidemiology trends @ Ascites Epidemiological Insights [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Ascites Emerging Drugs
* BIV201: BioVie
* OCE-205: Ocelot Bio
Ascites Drugs Market
The Ascites Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Ascites signaling in Ascites are likely to uncover new therapeutic targets and further expand treatment options for patients.
Ascites Treatment Market Landscape
The Ascites treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Ascites has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Ascites treatment guidelines, visit @ Ascites Treatment Market Landscape [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Ascites Market Outlook
The report's outlook on the Ascites market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Ascites therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Ascites drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Ascites market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Ascites Drugs Uptake
The drug chapter of the Ascites report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Ascites.
Major Ascites Companies
Several Ascites Companies working in the market include Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.
Learn more about the FDA-approved drugs for Ascites @ Drugs for Ascites Treatment [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Ascites Market Report
* Coverage- 7MM
* Ascites Companies- Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.
* Ascites Therapies- catumaxomab, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP Registered ), M701, Paracentesis, Recombinant Human Serum Albumin, and others.
* Ascites Market Dynamics: Ascites Market Drivers and Barriers
* Ascites Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Ascites Drugs in development @ Ascites Clinical Trials Assessment [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Executive Summary of Ascites
3. Competitive Intelligence Analysis for Ascites
4. Ascites: Market Overview at a Glance
5. Ascites: Disease Background and Overview
6. Patient Journey
7. Ascites Epidemiology and Patient Population
8. Ascites Treatment Algorithm, Current Treatment, and Medical Practices
9. Ascites Unmet Needs
10. Key Endpoints of Ascites Treatment
11. Ascites Marketed Products
12. Ascites Emerging Therapies
13. Ascites: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Ascites Market Outlook
16. Ascites Market Access and Reimbursement Overview
17. Ascites KOL Views
18. Ascites Market Drivers
19. Ascites Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ascites-market-is-expected-to-showcase-a-significant-growth-at-a-cagr-of-x-by-2032-as-per-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ascites Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight here
News-ID: 3476970 • Views: …
More Releases from ABNewswire
Integris Roofing Expands Services to Houston, Offering Top-Quality Roof Repair S …
Integris Roofing, renowned for its commitment to excellence and unparalleled service in the roofing industry, has recently made a significant stride by expanding its services to Houston. This expansion marks a pivotal moment for both Integris Roofing and the residents of Houston, as it brings forth a new era of top-quality roof repair solutions to the area.
Houston, a bustling metropolis known for its dynamic energy and diverse architectural landscape, presents…
Schneider Electric invests Rs 100 cr in new cooling factory in Bengaluru
Schneider Electric, a global player in energy management and automation, has invested Rs 100 crore in a new cooling factory in Bengaluru, officially launched on Thursday. The company has also earmarked an investment of Rs 3,200 crore in India by 2026 to expand its presence across the country.
The cooling factory in Bengaluru, spanning about 6.5 acres, will focus on developing "innovative" cooling solutions to meet the growing exponential demand for…
Schneider Electric to invest 3,200 crore in India to grow footprint, enhance tec …
In a significant move that underscores its commitment to India's growing industrial and technological sector, Schneider Electric India plans to invest 3,200 crore to enhance its industrial footprint across the country by 2026. The expansion will include an addition of 12,00,000 square feet of space spread over nine states, including Gujarat, Telangana, Karnataka, West Bengal, Odisha, Tamil Nadu, Maharashtra, Himachal Pradesh, and Uttarakhand, Deepak Sharma, President-Greater India Zone and MD…
Schneider Electric Confirms Early Stage Talks to Acquire Bentley Systems
A visualization of the ITER tokamak fusion reactor created with Bentley's Lumen RT. Schneider Electric's interest in further digitization of the design and construction process may align with Bentley Systems' strong background in building information modeling and digital twins.
Schneider Electric SE, the French technology, electrical automation and energy management company, has said it is in talks for a potential deal to purchase a controlling stake in Bentley Systems, the Exton,…
More Releases for Ascites
Ascites Market Size, Share, Trends, Analysis and Forecast 2027
The Global Ascites Market is poised to register a CAGR of over 4% during the forecast period 2020 to 2027.
Ascites are a condition in which excessive fluid accumulates in the abdominal cavity. Ascites are most commonly caused by liver cirrhosis. Portal hypertension is a sign of its presence. Ascites may also be caused by heart failure, kidney failure, cancer, and pancreatic infection. The malignant ascites associated with ovarian cancer play…
Global Ascites Needle Market Analysis by 2020-2025
Global Info Research offers a latest published report on Ascites Needle Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Ascites Needle Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/Global-Ascites-Needle_p510224.html
Market…
Malignant Ascites Treatment Market: Competitive Dynamics & Global Outlook 2025
Market Research Report Store offers a latest published report on Malignant Ascites Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Malignant Ascites Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure…
Global Ascites Market Healthcare Analysis 2018 to 2023
Global and Chinese Ascites Industry, 2018 Market Research Report:
The 'Global and Chinese Ascites Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Ascites industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ascites manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.…
Malignant Ascites Treatment Market Opportunity Analysis - 2026
Ascites is the condition characterized by formation of excessive fluid in the abdominal cavity, particularly in the peritoneal cavity. It causes when the body is unable to eliminate out fluids. When ascites is developed due to cancer, it is called as malignant peritoneal effusion or malignant ascites. Malignancies that are most commonly associated with malignant ascites are cancers of breast, liver, ovary, lungs, lymphoma, and colon. In ascites condition, lymph…
Ascites Treatment Market Set to Surge Significantly During 2025
Peritoneal cavity is the space between lining of abdominal organs and abdomen. Accumulation of fluid in peritoneal cavity is refereed as ascites. In some cases, the condition is also referred as portal hypertension. Low levels of proteins (albumin) and portal hypertension i.e. high pressure in blood vessels of the liver results in ascites. Only 30% to 40% of the people suffering from ascites survive for around five years.
Report Overview @…
